Group One Trading, L.P. Cassava Sciences Inc Transaction History

Group One Trading, L.P.

$2.68 Billion
Q2 2025

A detailed history of Group One Trading, L.P. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 216,354 shares of SAVA stock, worth $501,941. This represents 0.01% of its overall portfolio holdings.

Number of Shares

216,354

Previous 94,925 127.92%

Holding current value

$501,941

Previous $142,000 175.35%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.19 - $2.24 $144,500 - $272,000	121,429 Added 127.92%	216,354 $391,000
Q1 2025 May 14, 2025	BUY	$1.5 - $3.02 $142,387 - $286,673	94,925 New	94,925 $142,000
Q3 2024 Nov 14, 2024	BUY	$9.57 - $35.08 $1.25 Million - $4.59 Million	130,789 New	130,789 $3.85 Million
Q1 2024 May 10, 2024	BUY	$18.44 - $26.41 $86,557 - $123,968	4,694 New	4,694 $95,000
Q2 2023 Aug 09, 2023	BUY	$21.59 - $27.88 $991,758 - $1.28 Million	45,936 New	45,936 $1.13 Million
Q4 2022 Feb 09, 2023	BUY	$27.82 - $44.16 $2.91 Million - $4.62 Million	104,520 New	104,520 $3.09 Million
Q2 2022 Aug 11, 2022	SELL	$17.22 - $38.47 $3.53 Million - $7.89 Million	-205,082 Reduced 89.65%	23,682 $666,000
Q1 2022 May 12, 2022	BUY	$32.6 - $53.05 $4.63 Million - $7.54 Million	142,102 Added 163.97%	228,764 $8.5 Million
Q4 2021 Feb 11, 2022	SELL	$36.77 - $90.91 $11.8 Million - $29.2 Million	-321,190 Reduced 78.75%	86,662 $3.79 Million
Q3 2021 Nov 12, 2021	SELL	$41.79 - $135.3 $5.71 Million - $18.5 Million	-136,733 Reduced 25.11%	407,852 $25.3 Million
Q2 2021 Aug 10, 2021	BUY	$32.15 - $89.72 $3.99 Million - $11.1 Million	124,202 Added 29.54%	544,585 $46.5 Million
Q1 2021 May 12, 2021	BUY	$7.09 - $87.95 $2.54 Million - $31.5 Million	358,594 Added 580.35%	420,383 $18.9 Million
Q4 2020 Feb 10, 2021	SELL	$6.79 - $12.25 $416,770 - $751,905	-61,380 Reduced 49.83%	61,789 $421,000
Q3 2020 Nov 12, 2020	SELL	$2.86 - $11.51 $281,601 - $1.13 Million	-98,462 Reduced 44.43%	123,169 $1.42 Million
Q2 2020 Aug 13, 2020	BUY	$2.04 - $9.64 $432,561 - $2.04 Million	212,040 Added 2210.82%	221,631 $683,000
Q1 2020 May 13, 2020	BUY	$3.26 - $9.65 $30,800 - $91,173	9,448 Added 6606.99%	9,591 $39,000
Q1 2019 May 13, 2019	BUY	$0.92 - $1.29 $131 - $184	143 New	143 $0

Others Institutions Holding SAVA

# of Institutions

131

Shares Held

14.2M

Call Options Held

963K

Put Options Held

866K

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $93M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Cassava Sciences Inc Transaction History